InsidersTradesSigma
Browse the full record of transactions filed by Johannes Hulthe, 董事. Insider active across 2 companies, notably Guard Therapeutics International AB (publ). Aggregated, 1 disclosures have been logged. Activity tracked since 4 April 2025. The latest transaction was filed on 4 April 2025 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Johannes Hulthe is a Board Member at Guard Therapeutics International AB (publ). He participates in strategic decisions and the governance of the company. His experience is valuable in guiding Guard Therapeutics in its research and development initiatives. Guard Therapeutics focuses on developing innovative treatments.